Regional tau burden emerges following beta-amyloid chronicity timeline in Down syndrome population

This research investigates the temporal and spatial progression of tau pathology in relation to beta-amyloid accumulation in individuals with Down syndrome. The study demonstrates a sequential pattern of neurochemical changes that may underlie cognitive decline and increased Alzheimer's disease risk in this population.